EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Epitranscriptomic sculpting: the role of m6A in alternative splicing, cancer progression, and methodological insights

Farag Altalbawy, Eman Raeed Azzam, Ali Alkhathami, Ahmed Hussn, H Malathi, Akanksha Bhatt, Aman Shankhyan, Priya Priyadarshini Nayak, Sami Almalki, Mohammed Jawad Alnajar

Medical Oncology · 2025

DOI: 10.1007/s12032-025-03045-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Oncology, 2025. Verfasst von Farag Altalbawy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University College of Duba, University of Tabuk, Tabuk, Saudi Arabia. Hauptthemen laut MEDLINE: Alternative Splicing, Neoplasms, Transcriptome, Adenosine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 138 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The burgeoning field of epitranscriptomics -modifications of RNA molecules that do not alter the underlying RNA sequence but affect gene expression- has unveiled m6A as a pivotal modulator of RNA fate, with profound implications for alternative splicing and cancer progression. This review synthesizes current evidence delineating the molecular mechanisms by which m6A deposition influences spliceosomal dynamics and RNA processing. Central to this process is the coordinated action of m6A "writers," "erasers," and binding proteins ("readers"), which collectively dictate transcriptome diversity through precise modulation of splicing decisions. Aberrant m6A modifications have been increasingly correlated with dysregulated splicing patterns that contribute to oncogenic transformation, tumor heterogeneity, and the emergence of aggressive cancer phenotypes. By integrating findings from recent studies, this article highlights the critical interplay between epitranscriptomic regulation and the alternative splicing machinery, underscoring how these interactions drive pathophysiological processes in cancer. Furthermore, the review explores emerging therapeutic opportunities targeting the m6A regulatory network, calling attention to its potential as both a prognostic biomarker and a novel intervention point in precision oncology. Through a comprehensive examination of the current literature, this analysis provides valuable insights into the role of m6A in sculpting the cancer transcriptome, offering a robust framework for future research endeavors in the field of cancer biology and therapeutic innovation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingNeoplasmsTranscriptomeAdenosineEpigenesis, GeneticHumansDisease ProgressionGene Expression Regulation, NeoplasticAnimals

Stichwörter der Autor:innen

Alternative splicingN6-methyladenosine (m6A)OncogenesRNA–protein interactionsSplice site recognitionTumor suppressor genes

Substanzen

AdenosineN-methyladenosine

Autor:innen und Institutionen

  • Department of Chemistry, University College of Duba, University of Tabuk, Tabuk, Saudi Arabia.
  • Medical Laboratory Techniques Department, College of Health and Medical Technology, University of Al-Maarif, Ramadi, Anbar, Iraq. Emanraeedazzam@gmail.com.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
  • Department of Medical Analysis, Medical Laboratory Technique College, The Islamic University, Najaf, Iraq.
  • Department of Medical Analysis, Medical Laboratory Technique College, The Islamic University of Al Diwaniyah, Al Diwaniyah, Iraq.
  • Department of Medical Analysis, Medical Laboratory Technique College, The Islamic University of Babylon, Babylon, Iraq.

Zitieren

APA

Altalbawy, F., Azzam, E. R., Alkhathami, A., Hussn, A., Malathi, H., Bhatt, A., Shankhyan, A., Nayak, P. P., Almalki, S., & Alnajar, M. J. (2025). Epitranscriptomic sculpting: the role of m6A in alternative splicing, cancer progression, and methodological insights. Medical Oncology. https://doi.org/10.1007/s12032-025-03045-0

Vancouver

Altalbawy F, Azzam ER, Alkhathami A, Hussn A, Malathi H, Bhatt A, et al. Epitranscriptomic sculpting: the role of m6A in alternative splicing, cancer progression, and methodological insights. Medical Oncology. 2025. doi:10.1007/s12032-025-03045-0

BibTeX
@article{Altalbawy2025,
  author = {Altalbawy, Farag and Azzam, Eman Raeed and Alkhathami, Ali and Hussn, Ahmed and Malathi, H and Bhatt, Akanksha and Shankhyan, Aman and Nayak, Priya Priyadarshini and Almalki, Sami and Alnajar, Mohammed Jawad},
  title = {Epitranscriptomic sculpting: the role of m6A in alternative splicing, cancer progression, and methodological insights},
  journal = {Medical Oncology},
  year = {2025},
  doi = {10.1007/s12032-025-03045-0}
}
Kostenlos starten →